======= XPO5 ======= == Gene Information == * **Official Symbol**: XPO5 * **Official Name**: exportin 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57510|57510]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9HAV4|Q9HAV4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=XPO5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20XPO5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607845|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the karyopherin family that is required for the transport of small RNAs and double-stranded RNA-binding proteins from the nucleus to the cytoplasm. The encoded protein translocates cargo through the nuclear pore complex in a RanGTP-dependent process. [provided by RefSeq, Aug 2011]. * **UniProt Summary**: N/A |Xpo1| |positive regulation of RNA interference| |RNA nuclear export complex| |pre-miRNA export from nucleus| |RISC complex binding| |regulation of RNA interference| |pre-miRNA binding| |nuclear export signal receptor activity| |RISC complex| |miRNA metabolic process| |positive regulation of posttranscriptional gene silencing| |Ran GTPase binding| |regulation of protein export from nucleus| |gene silencing by miRNA| |posttranscriptional gene silencing by RNA| |posttranscriptional gene silencing| |tRNA binding| |gene silencing by RNA| |regulation of gene silencing by RNA| |regulation of posttranscriptional gene silencing| |regulation of nucleocytoplasmic transport| |RNA export from nucleus| |regulation of gene silencing| |protein export from nucleus| |gene silencing| |nuclear export| |mRNA binding| |RNA transport| |nucleic acid transport| |establishment of RNA localization| |RNA localization| |regulation of intracellular protein transport| |regulation of gene expression, epigenetic| |nucleobase-containing compound transport| |nucleocytoplasmic transport| |nuclear transport| |regulation of intracellular transport| |ncRNA metabolic process| |posttranscriptional regulation of gene expression| |regulation of cellular protein localization| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of cellular localization| |intracellular protein transport| |regulation of protein localization| |RNA binding| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |RNA metabolic process| |negative regulation of gene expression| |establishment of localization in cell| |nitrogen compound transport| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|-2.92| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-2.46| |[[:results:exp31|Rifampicin 1μM R00 exp31]]|-2.43| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|-2.43| |[[:results:exp436|Dynasore 7μM R08 exp436]]|-2.38| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|-2.33| |[[:results:exp483|FTY720 3μM R08 exp483]]|-2.25| |[[:results:exp144|PFI-3 10μM R03 exp144]]|-2.23| |[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|-2.19| |[[:results:exp291|LLY-284 2.6μM R06 exp291]]|-2.14| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|-2.13| |[[:results:exp302|35°C R06 exp302]]|-2.12| |[[:results:exp421|VHL-ligand-1 20μM R07 exp421]]|-2.11| |[[:results:exp331|A-769662 20μM R07 exp331]]|-2.08| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|-2.08| |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|-2.07| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-1.99| |[[:results:exp170|Metformin 100 to 150μM on day4 R04 exp170]]|-1.99| |[[:results:exp239|PFI-2 4μM R05 exp239]]|-1.98| |[[:results:exp262|Alda-1 10μM R06 exp262]]|-1.97| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-1.95| |[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|-1.82| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-1.8| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|-1.77| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|-1.74| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-1.71| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|2.13| |[[:results:exp487|Hinokiflavone 12μM R08 exp487]]|2.36| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.556| |[[:human genes:s:spcs3|SPCS3]]|0.432| |[[:human genes:t:tsen34|TSEN34]]|0.426| |[[:human genes:g:gnb1l|GNB1L]]|0.425| |[[:human genes:a:alg13|ALG13]]|0.422| |[[:human genes:g:gfpt1|GFPT1]]|0.404| |[[:human genes:t:tti2|TTI2]]|0.402| Global Fraction of Cell Lines Where Essential: 306/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|9/28| |blood|9/28| |bone|4/26| |breast|13/33| |central nervous system|23/56| |cervix|2/4| |colorectal|6/17| |esophagus|6/13| |fibroblast|1/1| |gastric|6/16| |kidney|7/21| |liver|3/20| |lung|31/75| |lymphocyte|13/16| |ovary|9/26| |pancreas|12/24| |peripheral nervous system|4/16| |plasma cell|8/15| |prostate|0/1| |skin|13/24| |soft tissue|5/9| |thyroid|2/2| |upper aerodigestive|12/22| |urinary tract|19/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2085 * **Expression level (log2 read counts)**: 7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}